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ABSTRACT 
Rubinstein-Taybi syndrome (RSTS) is a complex autosomal-dominant disease 
characterized by mental and growth retardation and skeletal abnormalities. A majority of 
the individuals diagnosed with RSTS carry heterozygous mutation in the gene CREBBP, 
but a small percentage of cases are caused by mutations in EP300. To investigate the 
contribution of p300 to RSTS pathoetiology, we carried out a comprehensive and 
multidisciplinary characterization of p300
+/-
 mice. These mice exhibited facial 
abnormalities and impaired growth, two traits associated to RSTS in humans. We also 
observed abnormal gait, reduced swimming speed, enhanced anxiety in the elevated plus 
maze, and mild cognitive impairment during the transfer task in the water maze. These 
analyses demonstrate that p300
+/-
 mice exhibit phenotypes that are reminiscent of 
neurological traits observed in RSTS patients, but their comparison with previous studies 
on CBP deficient strains also indicate that, in agreement with the most recent findings in 
human patients, the activity of p300 in cognition is likely less relevant or more 
susceptible to compensation than the activity of CBP. 
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Introduction 
Rubinstein-Taybi syndrome (RSTS, OMIM #180849) is a complex autosomal-dominant 
disease characterized by mental impairment, growth retardation and characteristic 
skeletal abnormalities, such as apparent hypertelorism, prominent nose, malpositioned 
ears and broad thumbs and toes (Rubinstein and Taybi, 1963). Petrij and colleagues 
discovered fourteen years ago that about 40% of the individuals diagnosed with RSTS 
carried heterozygous mutations in CREBBP, the gene encoding for the CREB binding 
protein (CBP) (Petrij et al., 1995). Later studies have increased this number up to 60% of 
the individual diagnosed with this condition (Bentivegna et al., 2006), and revealed that a 
small percentage (~3%) of cases diagnosed as RSTS were caused by mutations of the 
gene EP300, which encodes for the co-activator p300 that is highly homologous to CBP 
(Bartholdi et al., 2007; Roelfsema et al., 2005; Zimmermann et al., 2007).  
CBP and p300 proteins function as co-factors for many transcription factors 
(Chan and La Thangue, 2001) including several transcription factors known to be 
regulated or induced by neuronal activity, such as CREB, c-Fos, c-Jun, or NF- . In 
addition, both proteins have histone acetyltransferase (HAT) activity that targets the N-
terminal unstructured tails of histones and may contribute to transcriptional activation by 
relaxing the structure of the nucleosomes (Ogryzko et al., 1996). Their role in activity-
dependent chromatin modification and gene expression may account for at least part of 
the cognitive and physiological alterations associated to mental retardation in RSTS 
patients. 
Although the primary sequence of p300 and CBP are more than 70% similar and 
they have many common interaction partners, these two proteins have distinct cellular 
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functions and cannot always replace one another (Kalkhoven, 2004). The recent 
characterization of a number of mouse strains deficient in CBP activity has provided 
important new insight into the role of CBP in RSTS molecular etiology and opened new 
therapeutic avenues to treat this condition (Alarcon et al., 2004; Bourtchouladze et al., 
2003; Korzus et al., 2004; Wood et al., 2006; Wood et al., 2005; reviewed in Barco, 
2007). In contrast, the role of p300 in cognition and behavior remains poorly explored, 
although it has been recently shown that conditional transgenic mice expressing an 
inhibitory truncated form of p300 had mild memory deficits (Oliveira et al., 2007). 
Here, we carried out a comprehensive analysis, including anatomical, behavioral, 
biochemical and gene profiling assays, of mice bearing a deleted p300 allele. Our results 
demonstrate skeletal abnormalities reminiscent of RSTS, mild motor and cognitive 
deficits and enhanced anxiety in the elevated plus maze, but unaltered levels of acetylated 
histones and negligible changes in gene expression except for p300 itself. In agreement 
with recent conclusions of studies in human patients, the comparison of the behavioral 
phenotypes of cbp and p300 mutants indicates that CBP, as compared to p300, plays a 
major role in cognitive abilities. 
 
Materials and Methods 
Animals 
The generation of cbp
+/-
 (Tanaka et al., 1997) and p300
+/-
 (Yao et al., 1998) mice has 
been described before. CBP deficient mice were maintained in a mixed genetic 
background (F2 of C57BL/6J and DBA) because they cannot be maintained into a pure 
C57BL/6J background (Alarcon et al., 2004). P300 deficient mice were maintained in a 
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C57BL/6J pure background at least otherwise is indicated. Mice were group housed in 
single-sex cages on a light:dark cycle (12/12 h) with food and water available ad libitum. 
The wild type mice used as control were, in all cases, littermates of the mutant mice. 
Mice were maintained according to animal care standards established by the European 
Union and all the protocols were approved by the Institutional Animal Care and Use 
Committee. 
Behavior 
For all behavioral tasks, we used adult male mutant and control littermates in a C57BL/6J 
pure background. The experimenter was blind to genotypes. The result of the PCR-based 
genotyping was provided as a factor for statistical analysis of the behavioral data once the 
battery of tasks was concluded. SHIRPA primary screen. Mice were conducted using a 
modification of Irwin procedure (Irwin, 1968) as previously described (Rogers et al., 
1997; Viosca et al., 2008). Statistical analyses used t-tests and Mann Whitney tests. Open 
field: Mice were placed in 50 × 50 cm
2
 open-field chambers (170 lux on the floor) and 
monitored throughout the test session
 
(30 min) by a video-tracking system (SMART, 
Panlab S.L., Barcelona), which monitors up to four animals simultaneously and records 
the position of each animal every 0.5 sec. Data were analyzed with repeated measures 
ANOVA with “genotype” as the between subject factor and “time bin” as the repeated 
factor. Anxiety Test: Mice were placed in the center of the elevated plus maze and their 
behavior was recorded for 5 min with a camera located above the maze using SMART 
software. Time spent and number of entries in the different compartments (closed and 
open arms) were assessed. Lighting levels were 210 lux in the open arms and 45 lux in 
the closed arms. Data were analyzed using t-test. Rotarod: Mice were first trained on a 
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rotarod (PanLab, S.L, Barcelona) at a constant speed (~4
 
rpm). Mice received three trials 
per day for three days. A steady level of performance was attained in both genotypes. On 
the
 
testing day, the rotarod was set to increase 1 rpm every 30 sec starting at 4 rpm and 
the interval for mice to fall off was measured. T-test was used for statistical analysis. 
Object recognition: This task was performed as previously described (Viosca et al., 
2008), with a 15 minutes training session and a 15 minutes testing session 24 h after 
training. The use of different objects as novel or familiar, as well as the relative position 
of the novel object, was balanced between genotypes. Exploration times during training 
were analyzed using a repeated measures ANOVA including  “genotype” and “training 
object” as between subject factors and “object location” as the repeated factor. 
Exploration times during testing were analyzed using a repeated measures ANOVA 
including “genotype” and “training object” as between subject factors and “object” (new 
vs old) as the repeated factor. Water Maze: The task was performed as previously 
described (Viosca et al., 2008). The experiment was divided in three phases: three days of 
visible platform task (V1-V3), eight days of hidden platform task (H1-H8), and five days 
of transfer task (T1-T5) in which the hidden platform was moved to the opposite corner. 
To evaluate the retention of the previously acquired information, three probe trials (P1-
P3, indicated by arrows in Figure 3) of 60 sec duration, in which the platform was 
removed, were performed 24 h after session H4, H8 and T5. Four trials, 120 s maximum 
and 30-60 min ITI (inter-trial interval) were given daily. For each session, the scores of 
the four trials were averaged for each individual. Path length, time in walls and swim 
speed were analyzed using Repeated measures ANOVAs including “genotype” as the 
between subject factor and “session” as the repeated factor. For the analysis of probe 
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trials, we calculated quadrant occupancy (% of time) and the number of crossings in an 
annulus (area double than platform) located at platform position (TQ, target quadrant) 
and at equivalent positions in the other three quadrants of the pool. T-tests and Repeated 
measures ANOVAs including “genotype” as the between subject factor and “quadrant” 
as the repeated factor were used for their analysis. Fear conditioning: On training day, 
the mice were placed in the conditioning chamber (Panlab S.L., Barcelona, Spain) for 2 
min before the onset of a tone at 2800 Hz, 85 dB (conditioned stimulus, CS), which 
lasted for 30 s. The last 2 s of the CS were paired with a 0.7 mA foot shock 
(unconditioned stimulus, US). After an additional 30 s in the chamber, mice were 
returned to their home cage. Conditioning was assessed 24 h later by scoring freezing 
behavior using a piezoelectric accelerometer that transduced animal movements. The 
software (Freezing from Panlab S.L., Barcelona, Spain) was configured to consider an 
interval longer than 2 sec in which the signal remained below a given threshold as a 
freezing episode. Testing occurred first in the context in which mice were trained 
(contextual fear conditioning) and three hours later in a novel environment in which, after 
a 1 min of habituation, the same tone that was presented during training was given during 
120 s (cued fear conditioning). 
CT scan 
CT acquisition was performed with an ARGUS PET/CT (SUINSA Medical Systems, 
S.A., Madrid, Spain), using an amperage of 150 mA and a voltage of 45 kV. Mice were 
anesthetized with inhaled isofluorane (5% for induction, 2% for maintenance) during 
acquisition. Raw images were reconstructed using FDK algorithm with a voxel size of 
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0.25 x 0.25 x 0.25 mm
3
. Mid sagittal skull planes from wild type and mutant mice were 
aligned and compared using MHWKS (GE Healthcare, Chalfont St. Giles, UK) software. 
Western blot and histological techniques  
Nissl staining, hippocampal protein extracts and Western blot analysis were carried out as 
previously described (Alarcon et al., 2004). Antibodies recognizing total levels of 
histones H2B and H3 were obtained from Upstate (Charlottesville, USA) and Abcam 
(Cambridge, UK) respectively. The different acetyl-histone antibodies, specific for the 
panacetylated forms of H2A (K5, K9), H2B (K5, K12, K15, K20), H3 (K9, K14) and H4 
(K5, K8, K12, K16), were produced in our laboratory.  Western Blot results were 
statistically analyzed using t-tests. For immunohistochemistry, mice were anesthetized 
with a mix of ketamine and xylazine, perfused with 4% paraformaldehyde and postfixed 
overnight. 50 µm sections were obtained using a vibratome and stained as described 
(Lopez de Armentia et al., 2007). Antibodies against MAP2 and Synaptophysin were 
obtained from Sigma-Aldrich Química S.A. (Barcelona, Spain). As controls for the 
detection of changes in the acetylation of neuronal histones, we used protein samples and 
brain sections from mice intraperitoneally injected with sodium butyrate at a dose of 1.2 
g/kg and sacrificed 30 min after injection.  
Microarray analysis and quantitative RT-PCR 
We obtained triplicate samples containing total RNA from the hippocampi of four 3-
month old females of either genotype (in total 12 p300
+/-
 mice and 12 wild type 
littermates were used in the experiment). Mouse Genome 430 2.0 genechips were 
hybridized, stained, washed and screened for quality according to the manufacturer's 
protocol. The microarray
 
data was normalized and statistically analyzed using 
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GeneSpring GX (Agilent Technologies, Santa Clara, CA). The list of significantly 
changed probe sets shown in Supplemental Table 1 was obtained after filtering by signal 
intensities (20-100
th
 percentile in the raw data), statistical significance (P<0.05) and fold 
change (>1.5). Parametric and non-parametric tests rendered similar results. This dataset 
will be accessible at the GEO database upon acceptance of the manuscript. qRT-PCR was 
carried out in an Applied Biosystems 7300 real-time PCR unit using SYBR GreenER 
qPCR supermix (Invitrogen, Carlsbad, CA) and primers specific for p300, CBP, GAPDH 
and the other genes show in Figure 6. Each independent sample was assayed in duplicate 
and normalized using GAPDH levels. 
Results  
Facial dysmorphia and other syndromic features in p300 deficient mice 
Although preliminary studies indicated that mice bearing an inactive p300 allele did not 
show any gross skeletal malformation during development (Yao et al., 1998), we 
observed that a large percentage of adult p300
+/-
 mice (~75%) presented facial 
dysmorphia characterized by a prominent forehead and blunt nose (Figure 1A). This 
observation was confirmed using computerized tomography (CT) analysis, which 
revealed normal cranial length and width, but shortened and depressed nasal bridge in 
p300
+/-
 mice (Figure 1B, left). For comparison purposes, we also performed CT scans of 
cbp
+/-
 mice, which also confirmed the pronounced facial dysmorphia phenotype (Figure 
1B, right). 
 P300
+/-
 mice also showed other syndrome-related features like postnatal growth. 
Thus, adult p300
+/- 
mice exhibited reduced body weight (Figure 1C: wt=28.6±0.8 g, 
p300
+/-
=24.9±0.5 g, t44=3.598, p=0.001) and length (Figure 1C: wt=87.7±1.0 mm, p300
+/-
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=83.9±0.7 mm, t28=2.749, p=0.010). Despite the marked alteration of skull morphology, 
Nissl staining and immunohistochemistry of brain sections using the neuronal markers 
MAP2 and synaptophysin did not reveal gross abnormality in the brain of p300
+/-
 mice 
(Figure 2). 
 
Interaction of phenotype with genetic background 
In the proceeding of these experiments, we observed a reduced transmission of the p300 
mutant allele (Table 1: p<0.001, Fisher’s exact test). We were able to rescue this 
phenotype by transferring the mutation from a pure C57BL/6J genetic background to a 
mixed genetic background (50% DBA, 50% C57BL6/J), in which the expected 
mendelian ratio was observed (Table 1). Interestingly, previous studies on cbp
+/-
 mice had 
also revealed the interaction of CBP deficiency with the genetic background (Alarcon et 
al., 2004). Mice maintained in the mixed phenotype still exhibited facial dysmorphia, 
although milder than in the pure background, and impaired postnatal growth (Figure 1D: 
weight: wt=32.1±0.6 g, p300
+/-
=28.3±0.5 g, t37=4.053, p<0.001; length: wt=105.8±2.6 
mm, p300
+/-
=97.8±2.0 mm, t14=2.428, p=0.029). These results support an interaction 
between genetic background and the expression of p300 deficiency.  
 
Neurological examination, emotivity and exploratory behavior in p300
+/-
 mice 
We carried out a comprehensive behavioral analysis of p300
+/-
 mice aimed to model 
some of the neurological traits observed in RSTS patients. First, we subjected p300
+/-
 
mice to a battery of basal neurological tests. No differences were observed between 
p300
+/-
 mice and control siblings in basic reflexes, strength, muscle tone and many other 
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parameters evaluated in this primary screen (Table 2). However, mutant mice exhibited 
low pelvic elevation during ambulation (Figure 3A: wt=1 out of 11 animals (9%), p300
+/-
=6 out of 10 animals (60%); p=0.024, Fisher´s exact test). We also examined the 
performance of p300
+/-
 mice in an accelerated paradigm for the RotaRod, a test of motor 
coordination and learning, and we did not find significant difference between genotypes 
(Figure 3B, wt=210.2±28.6 sec, p300
+/-
=247.2±28.8 sec, 5 wt and 8 mutants, t11=-0.856, 
p=0.410). 
 We next examined the behavior of p300
+/-
 mice in an open field, a test for basic 
locomotor and exploratory behavior. Mutant mice showed normal exploratory activity as 
assayed by ambulatory distance, walking speed and other parameters (Figure 3C: F(1,19) 
genotype=2.039, p=0.170; F(5,95) bin x genotype=0.510, p=0.768; and results not shown). We 
found no differences between mutant mice and their wild type siblings in the time spent 
in the center of the arena, a common measure of anxiety (Figure 3D: F(1,19) genotype=0.535, 
p=0.473; F(5,95) bin x genotype=0.300, p=0.912). We also studied these mice in the elevated 
plus maze, a task where mice face a conflict between their tendency to explore new 
environments and their innate aversion to open, brightly light spaces. Mutant mice 
showed a reduced number of arm entries (Figure 3E: t18=3.306, p=0.004) and spent less 
amount of time in the open arms (Figure 3F: t18=2.324, p=0.032), suggesting enhanced 
anxiety in p300
+/-
 mice.  
 
Cognitive abilities in p300
+/-
 mice 
We next examined the performance of p300
+/-
 mice in a battery of cognitive tasks to 
assess whether a reduced level of p300 effected learning and long-term memory 
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formation. P300
+/-
 mice were first evaluated in a novel object recognition task, a non 
aversive memory task that relies on the natural exploratory behavior of mice. During 
training, both genotypes spent similar time exploring the objects and did not show a 
preference for either one of the identical objects. During testing, both mutant and wild-
type littermates spent more time exploring the novel object (Figure 4A: F(1,12) object= 
9.790, p=0.009), without differences between genotypes (F(1,12) genotype x object= 0.646, 
p=0.437) indicating a similar 24 h recognition memory for the old object. 
 We then examined the performance of p300
+/-
 mice in spatial navigation using the 
Morris water maze. We divided the experiment in three phases: (a) the visible platform 
task (3 days) to evaluate vision, motivation and swimming performance, (b) the hidden 
platform task (8 days) to examine spatial learning, and (c) the transfer task (5 days), in 
which the hidden platform was relocated in a different quadrant, to examine learning 
flexibility. We assessed spatial memory performing probe trials on days 5 and 9 of the 
hidden platform task and day 6 of the transfer task. During training in the visible platform 
task, mutant mice and control siblings did not differ in escape path length or latency 
(Figure 4B: F(1,19) genotype=1.880, p=0.186, F(2,38) genotype x session=1.414, p=0.256; and results 
not shown). In agreement with our observations in the elevated plus maze, mutant mice 
showed more thigmotaxis, an indication of enhanced anxiety (Figure 4C: F(1,19) 
genotype=8.029, p=0.011; F(2,38) genotype x session=0.178, p=0.837). Interestingly, p300 deficient 
mice, like CBP deficient mice (Alarcon et al., 2004), swam slower than their control 
littermates during the visible platform task (Figure 4D: F(1,19) genotype=5.636, p=0.028; 
F(2,38) genotype x session=0.018, p=0.982). The same trend toward reduced swimming speed 
was also observed during training in the hidden platform task (Figure 4D: F(1,19) 
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genotype=3.967, p=0.061; F(7,133) genotype x session=0.783, p=0.387). In contrast, we did not 
longer observe enhanced thigmotaxis (Figure 4C: Hidden: F(1,19) genotype=0.338, p=0.568; 
Transfer: F(1,19) genotype=1.746, p=0.202). P300
+/-
 mice performed as well as control 
siblings both in escape latency and path length indicating normal spatial learning. The 
probe trials carried out on day H5 and 24 h after H8 did not reveal significant differences 
between genotypes (Figure 4E and Supplemental Figure S1A-B). In contrast, we found 
that p300
+/-
 mice showed a significant delay in learning the new platform position in the 
transfer task (Figure 4B: from T2 to T5, F(1,19) genotype=5.552, p=0.029). In fact, p300
+/-
 
mice spent significantly more time in the quadrant of the pool were the platform was 
originally located (Figure 4F: from T2 to T5, F(1,19) genotype=5.058, p=0.037), suggesting 
that p300
+/-
 mice could be less flexible than their control littermates. This initial deficit in 
the transfer task was overcome with further training and p300
+/-
 mice and control siblings 
performed equally well a third probe trial (Figure 4G: wt=54±2%, p300
+/-
=47±6%, 
p=0.285; and Supplemental Figure S1C), indicating that mutant mice were able to learn 
the new platform location. 
 We concluded our behavioral analysis examining two forms of associative 
memory: contextual and cued fear conditioning. These tasks measure the capability of the 
mouse to form an association between an aversive stimulus (mild foot shock) and neutral 
environmental cues (context) or a tone (cued). We did not observe any significant 
difference between genotypes neither during training nor testing (Figure 4H). 
 
Chromatin acetylation in p300
+/-
 mice 
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We have previously reported that cbp
+/-
 mice had a specific deficit in histone H2B 
acetylation (Alarcon et al., 2004), whereas a recent study showed that transgenic mice 
expressing a truncated form of p300, p300 , had a mild reduction in the acetylation level 
of histone H3 in the hippocampus (Oliveira et al., 2007). We investigated the acetylation 
state of all four core histones in bulk chromatin of hippocampal tissue in p300 deficient 
mice and control siblings (Figures 5A-B). We did not observe any significant change in 
the global level of acetylation of histones H2A, H2B, H3 and H4 in the hippocampus of 
p300
+/-
 mice (Figure 5B, top: total H2B, p=0.659; total H3, p=0.990; AcH2A, p=0.717; 
AcH2B, p=0.600; AcH3, p=0.427; AcH4, p= 0.910; n=3 per genotype). Hippocampal 
samples of cbp
+/-
 mice, in which we confirmed the specific deficit in histone H2B 
acetylation (Figures 5A-B, p=0.003, n=4 per genotype), as well as hippocampal extracts 
from wild type mice treated with the inhibitor of histone deacetylases (HDACi) sodium 
butyrate and displaying histone hyperacetylation (Figure 5A), were included as controls 
in this analysis. To confirm the negative result in p300
+/-
 mice and extend our analysis to 
other brain regions, we immunostained sagittal brain sections of p300
+/-
 and wild type 
mice with antibodies against different acetylated histones. No difference between 
genotypes was detected although our technique revealed a dramatic increase in the 
acetylation level of the four histones by sodium butyrate (Figure 5C). 
 
Gene profiling in the hippocampus of p300
+/-
 mice 
More than 10% of known transcription factors have been shown to interact with the 
coactivators CBP and p300. In fact, p300 exhibits one of the largest connectivity found in 
interactome analyses (Kasper et al., 2006). Therefore, it would not be surprising that the 
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loss or reduction of p300 caused broad and dramatic alterations in gene expression. To 
identify those genes whose expression was altered in the hippocampus of p300 deficient 
mutants, we performed a gene profiling analysis of hippocampal tissue using high-density 
oligonucleotide microarrays. Unexpectedly, we found that p300 heterozygous mice did 
not show dramatic changes in gene expression. Statistical filtering revealed very few 
significant changes and fold changes were never larger than 2. In fact, only 16 probe sets 
showed a significant fold change larger than 1.5 (Supplementary Table 1). Moreover, 
most of these weak changes could not be validated by quantitative real-time RT-PCR 
analysis (Figure 6).  Importantly, this list included the probe set targeted to p300 
transcripts, whose downregulation was confirmed by qRT-PCR (p<0.001). We did not 
find significant changes in the expression of cbp neither in the microarray nor in the qRT-
PCR analyses (Figure 6; p= 0.613), indicating that p300 deficiency does not cause the 
compensatory upregulation of its paralogous gene. 
 
Discussion  
We carried out a comprehensive neurological characterization of adult p300
+/-
 mice. We 
did not observe gross neuroanatomical changes or alterations in histone acetylation or 
gene expression. Our analysis, however, revealed impaired growth and facial 
dysmorphia, two traits associated to RSTS in humans. We also observed abnormal gait, 
reduced swimming speed, enhanced anxiety in the elevated plus maze, and mild cognitive 
impairment during the transfer task in the water maze. Behavioral studies of individuals 
suffering from RSTS have revealed poor coordination and impaired learning of motor 
skills, as well as short attention span, stubbornness, sudden mood changes during early 
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adulthood and anxiety-related behaviors, such as the obsessive-compulsive disorder 
described in some patients (Hennekam et al., 1992; Levitas and Reid, 1998). Some of the 
phenotypes detected in p300
+/-
 mice are therefore reminiscent of neurological traits 
observed in RSTS patients.  
 Previous studies on p300 deficient mice were limited to the assessment of motor 
performance at the rotarod in mice bearing homozygous mutations in the KIX domain 
(Oliveira et al., 2006), which revealed no phenotype, and the evaluation of hippocampus-
dependent memory in transgenic mice expressing a putative dominant negative p300 
variant (Oliveira et al., 2007). Our analysis extends these studies both in its scope, we 
examined p300
+/-
 mice in a comprehensive battery of behavioral tasks and performed 
additional assays, such as CT and microarray analyses, as well as in its potential to model 
RSTS pathoetiology since the genetic mutation in the strain investigated here, a deletion 
of exons 4-6 (Yao et al., 1998), resembles the situation of 3 out of 6 identified RSTS 
patients bearing mutations on EP300 (Foley et al., 2009; Roelfsema and Peters, 2007) 
(Table 4). Previous studies in homozygous mice have provided compelling evidence of 
the effects of this mutation in mouse physiology, including early embryonic lethality 
(Phan et al., 2005; Yao et al., 1998). Despite the dramatic effects of the mutation in 
homozygosis, the analysis of heterozygous mice revealed relatively modest neurological 
deficits and a strikingly small impact on gene expression. Other than the expected 
reduction in the level of p300 messenger, we could not confirm additional changes in 
hippocampal gene expression. The absence of changes in CBP expression, both in adult 
p300
+/-
 mice (Figure 5D) and in p300
+/-
 and p300
-/-
 embryos (Yao et al., 1998) discards 
that the compensatory upregulation of its paralogous gene underlays the relatively modest 
Viosca et al. 
11/8/09 17  
impact of p300 deficiency. The comparison of CBP and p300 deficient mice in other 
areas of research has revealed that these two coactivators play distinct functions in 
myogenesis (Roth et al., 2003) and T-cell development (Kasper et al., 2006). The 
comparison of the results presented here with those previously shown for CBP deficient 
mice suggest that CBP and p300 also play unique roles in the nervous system.  
 Recent studies on RSTS patients have revealed that the mutations in the EP300 
locus are twenty times less frequent than in CREBBP locus. Although classical RSTS 
facial features and some skeletal malformation were observed in the six patients with 
mutations in the EP300 locus identified so far, none of them showed the classical 
malformations both on hands and feet that were originally considered mandatory for the 
diagnosis of RSTS (Bartholdi et al., 2007; Foley et al., 2009). Mental impairment in 
patients bearing mutations in EP300 also seems to be milder than in the average CREBBP 
patient (Bartholdi et al., 2007; Foley et al., 2009; Zimmermann et al., 2007). In fact, it has 
been suggested that most EP300 mutations could be underdiagnosed or associated with 
other phenotypes, instead of classical RSTS (Zimmermann et al., 2007). This 
underdiagnosis could be due to the fact that the mutation at the EP300 locus does not 
necessarily develop an observable RSTS condition because of individual differences in 
the expression of compensatory factors. This view is consistent with our results in mouse 
models showing that the reduction of p300 activity, although associated to postnatal 
growth impairment and some other syndromic traits, had milder effects in cognition than 
a similar reduction of CBP activity, and with our observation that genetic background 
influenced the viability and the strength of some phenotypes in p300
+/-
 mice.  This 
comparison highlights the specificity and relevance of the HAT activity of CBP in 
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cognition and neuronal plasticity revealed in previous studies (Alarcon et al., 2004; 
Korzus et al., 2004; Wood et al., 2005). 
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Figure legends 
Figure 1. Facial dysmorphia and growth retardation in mice with reduced HAT 
activity. A. Top view of the head of p300
+/-
, cbp
+/-
 and control mice. All the cbp
+/-
 mice 
(20 out of 20) and most of the p300
+/-
 mice analyzed exhibited a blunt nose (8 out of 13 
in a pure C57BL/6J background and 18 out of 24 in a DBA/C57 mixed background). The 
strongest dysmorphia was observed in cbp
+/-
 mice and in some p300
+/-
 mice in a pure 
genetic background. B. Computerized tomography analysis of p300 (left) and CBP (right) 
deficient mice skulls.  Sagittal sections from mutant (red) and control littermates (white) 
were overlapped and aligned for comparison. Cbp
+/-
 (3 out of 3) and, at lesser extent, 
p300
+/-
 mice in a pure C57BL/6J background (2 out of 3) showed depressed anterior 
frontal bone and shortened and depressed nasal bridge (blue arrows). We did not observe 
clear differences in the alignment of p300
+/-
 mice and control littermates in a DBA/C57 
background (3 out of 3, not shown). C-D. Reduced weight and body length of adult 
p300
+/-
 mice in a pure C57BL/6J background (C) and a mixed DBA/C57 background 
(D). (*) indicates significant differences between genotypes. 
Figure 2. Normal gross brain anatomy in p300 deficient mice. A. Nissl staining of 
coronal brain sections from p300
+/-
 (bottom) in a pure C57BL/6J background and wild-
type littermates (top). No apparent morphological defects were detected in brains from 
mutant mice (scale bar=1 mm). B-C. MAP2 (B) and Synaptophysin (C) inmunostaining 
of adult p300
+/-
 and control mice brain sections. Cytoarchitecture of hippocampus, 
cortex, amygdala and cerebellum (from top to bottom) were similar between mutant and 
wild-type mice (scale bar=200 m). 
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Figure 3. Locomotor activity and anxiety in p300 deficient mice. A. p300
+/-
 mice in a 
pure C57BL/6J background showed lower pelvic elevation during ambulation. (n=11 wt 
and 10 p300
+/-
). B. Rotarod performance of p300
+/-
 mice was normal (n=5 wt and 8 
p300
+/-
). C-D. Open field activity. p300
+/-
 mice (n=11) and control littermates (n=10) 
travelled similar distances (C) and spent the same time in the central area of the arena 
(D). E-F. In the elevated plus maze (11 mutant and 9 wild-type mice), p300
+/-
 mice 
showed reduced arm entries (E) and spent less time in the open arms (F). (*) indicates 
significant differences between genotypes. 
Figure 4. Cognitive abilities in p300 deficient mice. A. p300
+/-
 mice in a pure 
C57BL/6J background showed normal long-term memory for object recognition 24h after 
training (n=8 for each genotype). B-G. Spatial learning and memory in the water maze 
(p300
+/-
 mice: dark squares, n=10; wild type littermates: open circles, n=11). B. Both 
genotypes learned similarly in the visible and hidden platform tasks, but mutant mice 
showed significant impairments in the transfer task. C. p300
+/-
 mice showed enhanced 
thigmotaxis in the water maze during the first days of training in the visible platform task. 
D. p300
+/-
 mice showed reduced swimming speed in the water maze. E. Probe trials were 
performed on days H5 (P1) and H9 (P2) of training in the hidden platform task. No 
significant differences were observed in the two probe trials. F. In the transfer task, 
mutant mice explored more than wild-type littermates the quadrant were the platform was 
located during the hidden platform task. G. A third probe trial (P3) was performed 24 h 
after T5. No significant difference was observed. H. Contextual and cued fear 
conditioning is similar in p300
+/-
 (n=10) and wild-type (n=11) mice. (*) indicates 
significant differences between genotypes. 
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Figure 5. Bulk neuronal histone acetylation in p300 deficient mice. A. Western-blot 
of hippocampal protein extracts from p300
+/-
 in a pure C57BL/6J background and control 
(wt) mice using - -actin, -H2B (non acetylated), -AcH2B, -AcH2A, -AcH3 and 
-AcH4 antibodies (two left lanes). We analyzed in parallel samples from mice injected 
with sodium butyrate (NaBt) or vehicle (PBS) as a positive control (two central lanes). 
Western-blot of hippocampal protein extracts from cbp
+/-
 and control (wt) mice using the 
same antibodies (two right lanes). B. Quantification of western-blot results. No 
significant differences were found in the level of acetylation of hippocampal histones in 
p300
+/-
 mice (upper panel, n=3 for both genotypes). However, the quantification of 
western-blot results confirmed the specific deficit in acetylation of bulk histone H2B in 
the hippocampus of cbp
+/-
 mice (lower panel, n=4 for both genotypes). C. Images of the 
cellular layer in the CA1 subfield of p300
+/-
 mice and control littermates. Sagittal brain 
sections were immunostained with antibodies against acetylated forms of histones H2A, 
H2B, H3 and H4. The levels of histone acetylation were similar in both genotypes. As a 
control, we also present the staining of sections from wild type mice injected with the 
HDACi sodium butyrate or with vehicle (scale bar=100 m).  
Figure 6. Quantitative RT-PCR analysis of candidate genes revealed in the 
microarray screen. Total RNA was isolated from the hippocampi of p300
+/-
 mice and 
control littermates (n=4-5 per genotype). The following genes were assessed (from left to 
right): txnip (thioredoxin interacting protein, p=0.484); anxa4 (annexin A4, p=0.512); 
tspYl1 (testis-specific protein Y-encoded-like 1, p=0.253); vamp3 (vesicle-associated 
membrane protein 3, p=0.849); the RIKEN cDNA 1190005F20Rik (p=0.358); pank3 
(pantothenate kinase 3, p=0.968) and Ep300 (E1A binding protein p300, p<0.001). 
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Transcripts for crebbp (CREB binding protein, p=0.613) and histone cluster 1c (hist1h1c, 
p=0.640) were also assessed as controls. This analysis only revealed a significant 
reduction in the level of p300 mRNA. (*) indicates significant differences between 
genotypes.  
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Table 1: Viability of p300
+/-
 mice in a pure C57BL/6J and in a mixed C57/DBA 
genetic background 
 
 wild type
 
p300 
+/- 
P 
C57BL/6J 80 (78.4%) 22 (21.6%) <0.001 
C57/DBA 57 (54.3%) 48 (45.7%) 0.581 
 
For each genetic background, number and percentage of individuals obtained from wild-
type x heterozygote crosses are shown. The percentage of mutant mice was compared 
with same-sized samples following a mendelian distribution using Fisher’s Exact tests. 
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Table 2.  Neurological characterization of p300
+/-
 mice  
 Wild type
 
(n=11) p300
+/- 
(n=10) P 
Spontaneous activity 2 (2-2) 2 (2-2) 1.00 
 Locomotor activity 18 ± 1 16 ± 1 0.16 
Gait 0 (0-0) 0 (0-0) 1.00 
Palpebral closure 0 (0-0) 0 (0-0) 1.00 
Skin colour 1 (1-1) 1 (1-1) 0.16 
Daefecation 3 (2-4) 1.5 (1- 5.2) 0.25 
Tail elevation 2 (1-2) 1 (1-1.2) 0.05 
Pelvic elevation 3 (3-3) 2 (2-3) 0.02* 
Limb grasping 1 (1-1) 1 (1-1) 0.16 
Grip strength 3 (2-3) 3 (3-3) 0.08 
Negative geotaxis 0 (0-0) 0 (0-0) 1.00 
Touch escape 3 (3-3) 2 (2-3) 0.05 
Irritability 1 (1-1) 1 (1-1) 1.00 
Lacrimation 0 (0-0) 0 (0-0) 0.29 
Wire manoeuvre 2 (2-2) 2 (2-3) 0.65 
Fear  0 (0-0) 0 (0-0) 1.00 
Provoked biting 0.5 (0-1) 1 (0.5-1) 0.24 
Piloerection 0 (0-0) 0 (0-0) 1.00 
Body position 3 (3-3) 3 (3-3) 0.34 
Visual placing 2 (2-3) 3 (2-3) 0.18 
Transfer arousal 4 (4-5) 4 (4-5) 0.89 
Corneal reflex 1 (1-1) 1 (1-1) 1.00 
Righting reflex 0 (0-0) 0 (0-0) 1.00 
Contact righting réflex 1 (1-1) 1 (1-1) 1.00 
Pineal reflex 1 (1-1) 1 (1-1) 1.00 
Toe pinch 3 (2-3) 2 (2-2.5) 0.02* 
Trunk curl  0 (0-0) 0 (0-0) 1.00 
Tremor 0 (0-1) 0 (0-0.2) 0.70 
Abdominal tone 1 (1-1) 1 (1-1) 1.00 
Limb tone 1 (1-1) 1 (1-1) 0.29 
Urination 0 (0-1) 0 (0-0) 0.04* 
Vibrissae 0 (0-1) 0 (0-0.2) 0.70 
Vocalisation 1 (1-1) 1 (1-1) 1.00 
Data are expressed as either mean ± SEM or median followed by the interquartile range 
in parenthesis. P-values are calculated using t-test for data expressed as mean ± SEM or 
Mann-Whitney test for data expressed as median followed by the interquartile range. 
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Table 3. Mutations in EP300 locus in humans and mice 
 Mutation Protein Reference 
RTST patients    
Patient 1 Point mutation in exon 10 generating 
a Stop codon 
* R648X (Bartholdi et al. 2007) 
Patient 2 Deletion in exon 20 Q1209fsX1226 (Bartholdi et al. 2007) 
Patient 3 Microdeletion (8pb) in exon 15 S959fsX966 (Bartholdi et al. 2007) 
Patient 4 Deletion stretching from promoter to 
first intron 
* No protein (Bartholdi et al. 2007) 
Patient 5 Microdeletion (1pb) in exon 31 P2366fsX2401 (Zimmermann et al. 2007) 
Patient 6 Deletion of exons 3-8 * K243Xfs271 (Foley et al. 2009) 
Mouse strains    
p300
+/-
 Deletion stretching from exon 4 to 6  * ~aa330fsX (Yao et al. 1998; this study) 
p300 1 Truncated cDNA (Exons 1-16) under 
CaMKII promoter 
S1032X (Oliveira et al. 2007) 
p300
KIX/KIX
 Triple point mutation in the KIX 
domain (exon 10) in homozygosis 
Y630A, A634N, 
Y638A 
(Oliveira et al 2006) 
 
* Mutations leading to the production of no protein or short truncated proteins (<30% of 
full length). 
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